Oct 7 2010
Biomaterials are of vital importance in the medical device industry, both for the discovery and development of synthetic organs, aesthetic procedures, and personal healthcare products.
Overall, the biomaterials market is influenced by factors such as industry dynamics, population demographics, product compatibility, supply chains, healthcare financing, product-liability legislation, and regulatory standards. The recent economic downturn affected the global Collagen and HA-Based Biomaterials market, with sales plunging in 2009, and the decline continuing in 2010 as well. Nevertheless, the market is expected to recover and gain momentum from 2011, driven by the development of new products with wide application range.
The US represents the largest market for Collagen and HA-Based biomaterials, as stated by the new market research report on Collagen And HA-Based Biomaterials. The global economic slowdown severely affected the facial injectables market in North America during the end of 2008 and 2009, with a number of patients delaying or canceling their injectable treatment procedures. The market is, however, expected to regain momentum as the economy recovers. Japan and Europe are the other major markets for collagen and HA-Based biomaterials.
Collagen based biomaterials market is well established globally, but due to side effects, new innovative products have started capturing its market share. The recent FDA approvals of Botox, botulinum toxins, and hyaluronic-based injectables have enhanced growth in demand for injectables and other cosmetic surgery products. Botox is now much more widely used than collagen worldwide. Collagen also faces stiff competition from the newly introduced Hyaluronic Acid based facial injections. All this has led to considerable decline in demand for collagen biomaterials in the facial implants market. Hyaluronic-acid based biomaterials are forecast to register rapid growth in future, backed by increased patient preference.
Major players profiled in the report include Alcon Inc., Anika Therapeutics Inc., Bioniche Pharma USA LLC, Genzyme Biosurgery, Allergan Inc., Q-Med AB, and Seikagaku Corp.
The report titled “Collagen and HA-Based Biomaterials: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the Collagen and HA-Based Biomaterials market, impact of recession, current trends, growth drivers, new product introductions, recent industry activity, and focus on major and niche global market players. The study analyzes market data and analytics in terms of value sales for the global market by the following regions - US, Canada, Japan, Europe and Rest of World. Key product segments analyzed include Collagen-based Biomaterials (Urinary Incontinence Products, Corneal Shields, Facial Aesthetic Dermal Implants, and Wound Dressings), and Hyaluronic Acid-based Biomaterials (Viscosupplements, Viscoelastics, and Facial Aesthetic Dermal Implants).
Source: http://www.strategyr.com/